2024
Dissecting the association between gut microbiota, body mass index and specific depressive symptoms: a mediation Mendelian randomisation study
Yu T, Chen C, Yang Y, Wang M, Yang Y, Feng W, Yuan S, Ma X, Li J, Zhang B. Dissecting the association between gut microbiota, body mass index and specific depressive symptoms: a mediation Mendelian randomisation study. General Psychiatry 2024, 37: e101412. PMID: 38975363, PMCID: PMC11227829, DOI: 10.1136/gpsych-2023-101412.Peer-Reviewed Original ResearchActinobacteria phylumGut microbiotaBody mass indexSpecific depressive symptomsDepressive symptomsMendelian randomisationGenome-wide association studiesTwo-sample Mendelian randomisationMass indexDepressed moodAppetite changesMendelian randomisation studiesBifidobacteriaceae familyAssociation studiesActinobacteriaPhylumMR analysisGenusFamily XIMicrobiotaObservational studyMediation analysisClinical practiceGutProtective effect
2021
The effect of berberine adjunctive treatment on glycolipid metabolism in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
Li M, Liu Y, Qiu Y, Zhang J, Zhang Y, Zhao Y, Jia Q, Li J. The effect of berberine adjunctive treatment on glycolipid metabolism in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial. Psychiatry Research 2021, 300: 113899. PMID: 33812218, DOI: 10.1016/j.psychres.2021.113899.Peer-Reviewed Original ResearchConceptsAdjunctive treatmentNon-psychiatric patientsDouble-blindSerum prolactin concentrationsPlacebo-controlled clinical trialSchizophreniaMetabolic disturbancesGlycolipid metabolic parametersBaseline body mass indexImprove metabolic disturbancesLow-density lipoprotein cholesterolProlactin concentrationsSixty-five patientsFasting serum insulinWeek 8Body mass indexEffects of berberineLipoprotein cholesterolMass indexPlaceboWeek 4Previous studiesClinical trialsMetabolic parametersTotal cholesterol